[Treating a psychotic syndrome in 2007]

Area of Science:

• Psychiatry
• Neuroscience

Context:

• Psychotic symptoms are traditionally classified into positive, negative, and disorganization patterns.
• Electroconvulsivotherapy (ECT) and conventional neuroleptics were early treatments for psychosis.
• Current research focuses on identifying prepsychotic symptoms and novel therapeutic modalities like brain stimulation.

Purpose:

• To review the evolution of psychotic symptom treatment, focusing on antipsychotic medications.
• To highlight the advantages and challenges associated with atypical antipsychotics.
• To discuss complementary treatment strategies beyond pharmacotherapy.

Summary:

• Atypical antipsychotics demonstrate improved efficacy across the spectrum of psychotic symptoms, including emotional disturbances, and offer better tolerability compared to conventional neuroleptics.
• Despite advancements, challenges such as metabolic and cardiac risks associated with atypical antipsychotics, and patient compliance, persist.
• Effective management of psychotic syndromes necessitates integrated approaches, combining pharmacotherapy with supportive care, rehabilitation, and psychotherapy.

Impact:

• Atypical antipsychotics represent a significant advancement in managing the multifaceted nature of psychotic syndromes.
• Understanding treatment risks and improving patient compliance are crucial for optimizing therapeutic outcomes.
• Future research directions aim to refine early detection and explore innovative treatments, including brain stimulation techniques.